drug-discovery

To check drug-likeness and Lipinski compliance, you can evaluate molecules against Lipinski’s Rule of Five and Veber’s rules to predict oral bioavailability. This process calculates molecular properties like LogP and molecular weight to assess candidate viability.

You can retrieve bioactivity data by querying the ChEMBL database for compound activity against specific biological targets. This automated interface extracts bioactivity metrics to support medicinal chemistry workflows without requiring specialized local software.

Yes, you can look up drug-drug interactions and adverse event reports via OpenFDA. This safety and interaction assessment integrates public databases to evaluate potential metabolic liabilities and safety profiles of candidate molecules.

No, you do not need specialized local software to calculate molecular properties. This approach automates property calculation and drug-likeness screening using standard curl and python3 environments to execute API-driven data analysis.

The best way to verify molecular weight and LogP before synthesis is inputting the candidate molecule name to instantly retrieve its molecular properties. This assesses potential metabolic liabilities and supports lead optimization workflows.